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CONCLUSION 
 Microcytic erythrocytosis is an abnormal 
CBC (complete blood count) finding that 
is under-recognized, poorly understood, 
and consequently under-utilized in 
patient care. It is characterized by 
decreased MCV and increased RBC 
count. Its etiology is likely multifactorial 
and includes thalassemias and 
hemoglobinopathies. The focus of our 
study was to determine the relative 
prevalence of hemoglobin-associated 
disorders in patients revealing microcytic 
erythrocytosis on CBC and to 
demonstrate whether or not hemoglobin 
variant analysis should be included in the 
diagnostic work-up of such cases. 
 
The answer to the question our study title proposed i.e. “Is 
Hemoglobin Variant Analysis Helpful in the Diagnostic Work-up of 
Patients Revealing Microcytic Erythrocytosis on Complete Blood 
Count?” is unequivocally “yes”. Based on the observed extremely 
high positive yield of hemoglobin variant analysis in determining 
the etiology of erythrocytosis, we recommend that the abnormality 
of microcytic erythrocytosis should automatically be flagged and 
such specimens should be reflexively processed for hemoglobin 
variant analysis for each previously undiagnosed patient.  
METHODS 
INTRODUCTION 
Data from all CBCs within a 2 year period at 
Jefferson were reviewed, and patients 
meeting the inclusion criteria of microcytosis 
(MCV <80 fL) and erythrocytosis (RBC count 
≥5.2x106 T/L (Female) and >6x106 T/L 
(Male)) were selected. The sample size was 
137 patients with 87 females and 50 males; 
ages ranged from: 1-91 years with median 
age of 46 years. The racial distribution 
comprised of 49 Caucasians, 44 African 
Americans, 24 Asians and 20 unspecified. 
Hemoglobin values for the patients ranged 
from 7.2– 16.1 g/dL, MCVs ranged from 
54.5-79 fL and RBC count ranged from 5.2-
7.5x 106 T/L. 74 patients had mild anemia 
while 63 patients had hemoglobin levels 
within the gender-specified reference range. 
The results of hemoglobin variant analysis 
performed by high-performance liquid 
chromatography on these patients were 
reviewed.  
 
Hemoglobin Variant Analysis Pattern Consistent 
With 
Number of 
Patients 
Percentage 
of Patients 
Beta-thalassemia trait 70 51.1 
Delta/beta-thalassemia trait 1 0.7 
Hemoglobin E disease 4 2.9 
Hereditary persistence of fetal hemoglobin (HPFH) 1 0.7 
Possible HPFH 4 2.9 
Beta-thalassemia  with HPFH 2 1.5 
Delta/beta-thalassemia with iron deficiency anemia 1 0.7 
Hemoglobin C trait with beta-thalassemia 1 0.7 
Hemoglobin C trait with possible alpha-thalassemia 2 1.5 
Hemoglobin C with HPFH 1 0.7 
Unidentified hemoglobinopathy with possible 
delta/beta-thalassemia 
2 1.5 
Hemoglobin S trait combined with beta and 
possible alpha-thalassemia 
3 2.2 
Hemoglobin S trait with beta-thalassemia 1 0.7 
Normal pattern 44* 32.1 
Total # of patients 137 100 
Table 1:  Relative prevalence of hemoglobin-associated conditions in patients revealing microcytic 
erythrocytosis on CBC. 
DISCUSSION 
• 93 of the 137 (67.9%) had a thalassemia trait and/or a 
hemoglobinopathy. Amongst these, beta-thalassemia trait topped 
the list, followed by hemoglobin E disease, possible HPFH,HPFH 
and delta-beta-thalassemia.  
• The diagnosis of possible HPFH was entertained based on mild 
elevation of hemoglobin F (2.3% to 3.1%) by HPLC. Since HPFH is 
typically associated with normal MCV or RBC count, the microcytic 
erythrocytosis noted in these patients likely represent an associated 
undiscovered alpha-thalassemia trait.  
• Majority, if not all, of the 44 cases with normal hemoglobin variance 
analysis pattern also represent patients with possible α-thalassemia 
trait, Microcytic erythrocytosis is uncommon in normal patients and 
alpha thalassemia is a diagnosis of exclusion (requires DNA 
analysis studies not performed here) 
• Compound heterozygous conditions for either hemoglobinopathies 
and/or thalassemia(s) comprised 12 cases. Unspecified abnormal 
hemoglobins detected by the HPLC method remain unidentified as 
no additional analyses had been performed in both cases. 
• The diagnosis of delta/beta-thalassemia and concomitant iron 
deficiency anemia made in 1 patient was supported by the 
laboratory findings of increased hemoglobin F, decreased 
hemoglobin A2 and decreased serum ferritin. 
• With all these potential considerations, over 96% of the studied 
cases of microcytic erythrocytosis may be categorized as having a 
possible thalassemia trait and/or a hemoglobinopathy. 
 
Figure 1A) HPLC results of a patient with beta thalassemia trait B) HPLC results of a patient with 
Hemoglobin E disease 
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